
There are conflicting reports on cancer risk associated with zzso zzso zzso zzso zzso zzso zzso This retrospective cohort study was conducted to analyze the risk of cancer development in patients who received zzso zzso as treatment for essential zzso Using the Taiwan National Health Insurance Research zzso zzso eligible study patients with essential hypertension were zzso According to their zzso prescriptions, the study patients were zzso into an zzso inhibitor group, an zzso group, or a control zzso After matching, participants were observed for the occurrence of zzso In the zzso inhibitor group compared with the control group, the hazard ratio was zzso zzso confidence zzso zzso In the zzso group compared with the control group, the hazard ratio was zzso zzso confidence zzso zzso Regular use of zzso zzso was not associated with an increased risk of cancer development and was actually found to decrease overall cancer risk in this zzso 

